Daraprim
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
83649-330 -
Package NDC
83649-330-01 -
Package NDC
83649-330-03 -
Application number
NDA008578 -
SPL ID
c7c0666e-57ea-45e4-b3b4-e3950a173011 -
SPL set ID
f634f34b-0952-4dd3-9da3-f84b6ab823de -
UNII
Z3614QOX8W -
RxCUI
198182 -
RxCUI
201912
What the source publishes
- Labeler
- TILDE Sciences LLC
- Active ingredients
- pyrimethamine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Daraprim",
"splId": "c7c0666e-57ea-45e4-b3b4-e3950a173011",
"labels": [
{
"setId": "f634f34b-0952-4dd3-9da3-f84b6ab823de",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f634f34b-0952-4dd3-9da3-f84b6ab823de",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f634f34b-0952-4dd3-9da3-f84b6ab823de"
}
],
"routes": [
"ORAL"
],
"labeler": "TILDE Sciences LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE, PLASTIC (83649-330-01)",
"package_ndc": "83649-330-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20231212"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (83649-330-03)",
"package_ndc": "83649-330-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20231212"
}
],
"productId": "83649-330_c7c0666e-57ea-45e4-b3b4-e3950a173011",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "83649-330",
"deaSchedule": null,
"genericName": "pyrimethamine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PYRIMETHAMINE",
"strength": "25 mg/1"
}
],
"applicationNumber": "NDA008578",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19530123",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175934",
"N0000000191"
],
"upc": [
"0383649330012",
"0383649330036"
],
"unii": [
"Z3614QOX8W"
],
"rxcui": [
"198182",
"201912"
],
"spl_set_id": [
"f634f34b-0952-4dd3-9da3-f84b6ab823de"
],
"pharm_class_epc": [
"Dihydrofolate Reductase Inhibitor Antimalarial [EPC]"
],
"pharm_class_moa": [
"Dihydrofolate Reductase Inhibitors [MoA]"
],
"manufacturer_name": [
"TILDE Sciences LLC"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:83649-330_c7c0666e-57ea-45e4-b3b4-e3950a173011"